Hoffman William's Form 4 filing
Inari Medical, Inc.NARI · filed Feb 9, 2022
- Accession no.
- 0001562180-22-001313
- Filed
- Feb 9, 2022, 7:57 PM ET
- Trade date
- Feb 7, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.22M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman WilliamCIK 0001304099 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Common Stock | MOption exerciseAcquired | +30,000 | $0.428 | +$12,840 | 566,867 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −400 | $71.62F2 | −$28,649.2 | 568,287 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −6,367 | $73.33F3 | −$466,873.65 | 561,920 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −20,870 | $74.18F4 | −$1,548,132.43 | 541,050 | Direct | |
| Feb 7, 2022 | Common Stock | SSaleDisposed | −2,363 | $74.79F5 | −$176,740.11 | 538,687 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2022 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 200,467 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $71.43 to $72.2050. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $72.71 to $73.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $73.7250 to $74.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $74.74 to $74.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.